Surveillance for predisposition to MDS/AML. A general approach to surveillance is outlined. A discussion of low-risk clones is provided in the text. HSCT, hematopoietic stem cell transplant. *Excludes baseline dysplasia typically associated with specific disorders. **See text for additional discussion. ***For some disorders, chemotherapy may be considered to treat leukemia.